What is the generic name of Actos (pioglitazone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Generic Name of Actos

The generic name for Actos is pioglitazone hydrochloride 1.

Drug Classification and Chemical Identity

Pioglitazone belongs to the thiazolidinedione (TZD) class of oral antidiabetic agents 2. The complete chemical name is pioglitazone [(±)-5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione monohydrochloride, with a molecular formula of C19H20N2O3S•HCl and molecular weight of 392.90 daltons 1.

Available Formulations

Pioglitazone is available as oral tablets in three strengths:

  • 15 mg (as the base)
  • 30 mg (as the base)
  • 45 mg (as the base)

The tablets contain pioglitazone formulated with lactose monohydrate, hydroxypropylcellulose, carboxymethylcellulose calcium, and magnesium stearate 1.

Mechanism of Action

Pioglitazone functions as a potent agonist for peroxisome proliferator-activated receptor-gamma (PPARγ), decreasing insulin resistance in peripheral tissues and the liver. This results in increased insulin-dependent glucose disposal and decreased hepatic glucose output 1. Unlike sulfonylureas, pioglitazone is not an insulin secretagogue and requires the presence of endogenous insulin for its therapeutic effect 1.

Related Questions

What are the side effects of Actos (pioglitazone)?
What are the alternate names for Actos (Pioglitazone) and Farsigia?
What are the alternatives to Actos (Pioglitazone)?
How to safely discontinue Actos (pioglitazone)?
What is the optimal time of day to take pioglitazone?
What is the physiologic newborn skin desquamation (newborn skin peeling) condition?
What is the recommended dosing, monitoring, and contraindications for NUBEQA (darolutamide) in patients with non‑metastatic castration‑resistant prostate cancer receiving continuous androgen‑deprivation therapy?
In a 38-year-old female with major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and a history of marijuana use who is taking cariprazine (Vraylar) 3 mg daily, clonazepam 1 mg as needed, and vilazodone 40 mg daily, what specific questions should I ask during the initial evaluation to assess for attention-deficit/hyperactivity disorder?
What is the recommended surveillance imaging schedule after curative resection for stage II colon cancer that is microsatellite instability‑high (MSI‑high) and has a BRAF mutation?
Is standard troponin I screening useful in patients aged 65 years or older or with a Revised Cardiac Risk Index ≥ 1 undergoing major vascular or intermediate‑risk non‑cardiac surgery?
If a patient on morphine patient‑controlled analgesia (PCA) has required several rescue doses but I have less than a full 24‑hour record, how should I adjust the basal infusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.